No Detail Found!

Antibacterial activity of a peptide derived from HIV-1 MN strain gp41 envelope glycoprotein against methicillin-resistant Staphylococcus aureus.

Author(s)
Sin-Yeang Teow Oncological and Radiological Sciences, Advanced Medical and Dental Institute (AMDI),Universiti Sains Malaysia (USM), Bertam, Kepala Batas, Pulau Pinang,Malaysia
Syed Atif Ali Oncological and Radiological Sciences, Advanced Medical and Dental Institute (AMDI),Universiti Sains Malaysia (USM), Bertam, Kepala Batas, Pulau Pinang,Malaysia
Abstract
Peptides derived from HIV-1 transmembrane proteins have been extensively studied for antimicrobial activities, and they are known as antimicrobial peptides (AMPs). These AMPs have also been reported to potently combat the drug-resistant microbes. In this study, we demonstrated that peptide #6383 originated from HIV-1 MN strain membrane-spanning domain of gp41 was active (2-log reductions) at 100µg/mL (56.5µM) against methicillin-resistant Staphylococcus aureus (MRSA) in 10% and 50% human plasma-supplemented phosphate buffered saline (PBS). The activity was further enhanced (3-log reductions) in the presence of 5% human serum albumin (HSA) alone. All bactericidal activities were achieved within 6 hours. At 100µg/mL, the peptide showed only 13% toxicity against human erythrocytes. This peptide can serve as an attractive template for a design of a novel peptide antibiotic against drugresistant bacteria. By sequence-specific engineering or modifications, we anticipated that the bactericidal activity and the reduced toxicity against human erythrocytes will be improved.
Publication Details
Page(s) 2119-2124
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 29, Issue: 6, Year: 2016

Request the full text from PASTIC

Keywords
MRSA, antimicrobialpeptide, serumalbumin, hemolysis, plasma
0

Citations

0

Downloads

122

Views